Browse > Article

Discovery of Herbal Medicine Resources through Network Pharmacology Analysis Predicted to Be Useful for Tourette Syndrome  

Lee, Byoungho (Injoo Hospital of Korean Medicine)
Cho, Suin (School of Korean Medicine, Pusan National University)
Publication Information
Journal of TMJ Balancing Medicine / v.10, no.1, 2020 , pp. 12-20 More about this Journal
Abstract
Objectives: Tourette syndrome (TS) is a disease that occurs evenly in many social classes. Despite the long experience of drug treatment, the preference is low due to various side effects. The aim of this study was to discover herbal medicine resources through network pharmacology analysis predicted to be useful for Tourette syndrome. Methods: We used Traditional Chinese Medicine Systems Pharmacology Database and Analysis Platform (TCMSP) to identify herbal medicines that can be used for TS by using network pharmacology research methods and to predict the mechanism of action. After evaluating compounds of each identified herb, molecular target proteins and mechanisms of action were analyzed, focusing on compounds that are likely to exhibit clinical activity in consideration of the pharmacokinetic parameters of these individual compounds. Results: Fifty nine ingredients such as atropine, veraguensin, and nuciferin among the compounds contained in 48 types of medicinal herbs such as Daturae Flos (洋金花), Salviae Radix (丹参), and Nelumbinis Plumula (蓮子心) act on the D(2) dopamine receptor, which is a protein involved in the development of TS. It has been found that atropine, veraguensin, and nuciferin are highly likely to exhibit activity by acting on the G protein-coupled receptor signaling pathway. Conclusions: It can be used in conjunction with non-invasive treatment means such as FCST Yinyang Balancing Appliance with herbal therapy to bring about a significant therapeutic effect, and it will be possible to develop a treatment that can replace drug therapy used in Western medicine.
Keywords
Tourette's disorder; Systems biology; Traditional Korean medicine; Target protein; Action mechanism;
Citations & Related Records
Times Cited By KSCI : 2  (Citation Analysis)
연도 인용수 순위
1 Kenunen OG, Shchelkunov EL. Changes in neurovegetative regulation in the Tourette syndrome (according to ECG findings). Zh Nevropatol Psikhiatr Im S S Korsakova. 1987;87(6):907-910.
2 Paraga HC, Harris KM, Paraga KL, Balen GM, Cruz C. An overview of the treatment of Tourette's disorder and tics. J Child Adolesc Psychopharmacol. 2010;20(4):249-262.   DOI
3 Roessner V, Schoenefeld K, Buse J, Bender S, Ehrlich S, Muchau A. Pharmacological treatment of tic disorders and Tourette Syndrome. Neuropharmacology. 2013;68:143-149.   DOI
4 Steeves T, McKinlay BD, Gorman D, Billinghurst L, Day L, Carroll A, et al. Canadian guidelines for the evidence-based treatment of tic disorders: behavioural therapy, deep brain stimulation, and transcranial magnetic stimulation. Can J Psychiatry. 2012;57(3):144-151.   DOI
5 Dugosh K, Abraham A, Seymour B, McLoyd K, Chalk M, Festinger D. A systematic review on the use of psychosocial interventions in conjunction with medications for the treatment of opioid addiction. J Addict Med. 2016;10(2):91-101.
6 Roh HW, Hong CH, Lim HK, Chang KJ, Kim H, Kim NR, et al. A 12-week multidomain intervention for late-life depression: a community-based randomized controlled trial. J Affect Disord. 2020;263:437-444.   DOI
7 Kim JH, Jo HG, Seol JU. Review of clinical studies on traditional Chinese Medicine for Tourette syndrome. J of Oriental Neuropsychiatry. 2017;28(4):303-318.   DOI
8 Jung H, Sung WY, Lee S, Son JH, Han SH. A clinical report of a patient with Tourett's disorder. J of Oriental Neuropsychiatry. 2003;14(2):213-218.
9 Yu DG, Lee YJ. Tourette's disorder cases managed by Yinyang balancing appliance of FCST, a TMJ therapy for the balance of meridian and neurological system. TMJ Bal Med. 2012;2:17-19.
10 Wang H. A new strategy for integrated urban water management in China: Sponge city. Sci China Technol Sci. 2018;61(3):317-329.   DOI
11 Ru J, Li P, Wang J, Zhou W, Li B, Huang C, et al. TCMSP: a database of systems pharmacology for drug discovery from herbal medicines. J Cheminform. 2014;6:13.   DOI
12 Beck JM, Seo HK, Kwon YK. Review of network pharmacological approaches on Korean Medicine. J Physiol & Pathol Korean Med. 2016;30(6):419-425.   DOI
13 Xu X, Zhang W, Huang C, Li Y, Yu H, Wang Y, et al. A novel chemometric method for the prediction of human oral bioavailability. Int J Mol Sci. 2012;13:6964-6982.   DOI
14 Sandor P. Gilles de la Tourette syndrome:A neuropsychiatric disorder. J Psychosom Res. 1993;37(3):211-226. Cited from Gilles de la Tourette G. Etude sur nerveus caracterisee par de 1'incoordination motrice accompagnee d'echolatie et de coprolalie. Arch Neurol. 1885;9:19-42, 158-200.   DOI
15 Tao W, Xu X, Wang X, Li B, Wang Y, Li Y, et al. Network pharmacology-based prediction of the active ingredients and potential targets of Chinese herbal Radix Curcumae formula for application to cardiovascular disease. J Ethnopharmacol. 2013;145:1-10.   DOI
16 Verdellen C, van de Griendt J, Hartmann A, Murphy T. European clinical guidelines for Tourette syndrome and other tic disorders. Part III: behavioural and psychosocial interventions. Eur Child Adolesc Psychiatry. 2011;20:197-207.   DOI
17 Venditti S, Verdone L, Reale A, Vetriani V, Caserta M, Zampieri M. Molecules of silence: Effects of meditation on gene expression and epigenetics. Front Psychol. 2020;11:1767. doi: 10.3389/fpsyg.2020.01767.   DOI
18 Cotman CW, Berchtold. Exercise: a behavioral intervention to enhance brain health and plasticity. Trends Neurosci. 2002;25(6):295-301.   DOI
19 Yael D, Israelashvili M, Bar-Gad I. Animal models of Tourette syn-drome-from proliferation to standardization. Front Neurosci. 2016;10:132.
20 Min SK, Shin DW, Noh KS. A clinical study on Tourette's disorder. Korean J Child & Adol Psychiatr. 1997;8:92-100.
21 Comings DE, Himes JA, Comings BG. An epidemiological study of Tourette's syndrome in a single school district. J Clin Psychiatry. 1990;51:463-469.
22 Robertson. Annotation:Gilles de la Tourette Syndromean update. J Child Psychol Psychiat. 1994;35(4):597-611.   DOI
23 Huys D, Hardenacke K, Poppe P, Bartsch C, Baskin B, Kuhn J. Update on the role of antipsychotics in the treatment of Tourette syndrome. Neuropsychiatr Dis Treat. 2012;8:95-104.   DOI
24 Min SK, Lee H. A clinical study on Gilles de la Tourette syndrome in Korea. Br J Psychiatry. 1986;149:644-647.   DOI
25 Cavanna AE, Rickards H, Worrall R, Hoekstra PJ, Plessen KJ, Roessner V. From ipse dixit to evidence-based guidelines: on the optimal management of Tourette syndrome. Eur J Paediatr Neurol. 2012;16(3):310-311.   DOI
26 Shapiro AK, Shapiro E. Treatment of Gilles de la Tourette's Syndrome with haloperidol. Br J Psychiatry. 1968;114:345-350.   DOI